MedTrace Logo

Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Moderate to High Myopia

NCT00762541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2018-07-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether the MEL 80 Excimer Laser is effective in the treatment of moderate to high myopia (nearsightedness), when used as part of the Laser In Situ Keratomileusis (LASIK) procedure.

Conditions

  • Myopia

Interventions

DEVICE

MEL 80 Treatment of High Myopia

The reduction or elimination of myopia \> -7.00 D to -12.00 D, and astigmatism less than or equal to -6.00 D at the spectacle plane (myopia with or without astigmatism), with a maximum MRSE ≤ -12.00 D.

Sponsors & Collaborators

  • Carl Zeiss Meditec, Inc.

    lead INDUSTRY

Principal Investigators

  • John Doane, MD · Discover Vision Centers

  • Richard Hoffman, MD · Fine, Hoffman, and Packer LLC

  • Howard Fine, MD · Fine, Hoffman, and Packer LLC

  • Mark Packer, MD · FIne, Hoffman, and Packer LLC

  • David Tanzer, MD · US Navy Refractive Surgery Center, San Diego, CA

  • John Vukich, MD · Davis Duehr Dean Eye Clinic

  • Jon Dishler, MD · Dishler Laser Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-07-31
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762541 on ClinicalTrials.gov